Loading organizations...
§ Private Profile · 336 W 37th St, New York, New York 10018, US
Mixlab is a technology company.
Mixlab has raised $39.0M across 3 funding rounds.
Key people at Mixlab.
Mixlab has raised $39.0M in total across 3 funding rounds.
Mixlab operates as a veterinary pharmacy, providing compounded and commercial medications for animals. The company leverages PCAB-accredited facilities and its eMix platform to deliver high-quality pharmaceutical solutions. Offerings include diverse medication forms and flavors, alongside proactive communication and real-time order tracking, simplifying the prescription process for veterinarians and pet owners.
Frederic Dijols and Stella Kim co-founded Mixlab in 2017. Their insight was the need for more efficient, personalized veterinary pharmaceutical experience. They aimed to build a modern pharmacy prioritizing convenience, reliability, and enhanced service, addressing gaps in traditional medication delivery and support for animal care.
Mixlab serves a broad clientele, including pet owners, veterinarians, and organizations caring for animals. The company’s mission is to provide exceptional care for animals and their caretakers through personalized products and outstanding experiences. It strives to simplify medication management, foster trust, and improve animal well-being.
Mixlab has raised $39.0M across 3 funding rounds. Most recently, it raised $10.0M Other Equity in August 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 14, 2023 | $10M Venture Round | Ellis Fried | Andrew Mitchell, Lakehouse Ventures | Announced |
| Aug 1, 2021 | $20M Series A | Keith Levy | Flybridge Capital Partners, Greycroft, Partners Resolute, Surface Ventures, Brand Foundry Ventures, Global Founders Capital, Lakehouse Ventures, Monogram Capital Partners | Announced |
| Jun 1, 2019 | $9M Seed | — | Flybridge Capital Partners, GSR Ventures, Lightbank, Surface Ventures | Announced |
Mixlab has raised $39.0M in total across 3 funding rounds.
Mixlab's investors include Ellis Fried, Andrew Mitchell, Lakehouse Ventures, Keith Levy, Flybridge Capital Partners, Greycroft, Partners Resolute, Surface Ventures, Brand Foundry Ventures, Global Founders Capital, Monogram Capital Partners, GSR Ventures.
Mixlab is a tech-enabled veterinary pharmacy founded in 2017, specializing in compounded, commercial, and over-the-counter medications for pets, equines, and wildlife across all 50 U.S. states.[1][2][4] It serves veterinarians as a concierge service, offering customizable dosages, forms, and flavors to simplify prescription management and deliver personalized care to pet owners, addressing inefficiencies in traditional vet-led medication processes.[1][2][4] With $49.84M raised through Series A-II funding, Mixlab has shown strong growth, including a January 2025 acquisition of Midwest pharmacies that tripled its regional veterinary partners, alongside tech upgrades like a client portal for 24/7 order tracking and refills.[1][2]
Mixlab was founded in 2017 in New York City, with headquarters at 336 West 37th Street, evolving into a full-service, PCAB-accredited pharmacy that digitally transforms veterinary prescriptions.[1][2][4][5] While specific founders are not detailed in available sources, the company emerged to tackle fragmented pet medication delivery, prioritizing custom compounding and user-friendly experiences for vets and pet parents.[2][3][4] Early traction built on its tech stack—including React, Ruby on Rails, and tools like Salesforce and HubSpot—enabling rapid scaling to 130 employees across New York and Los Angeles offices, with hybrid work and recent expansions like the 2025 Midwest acquisitions marking pivotal growth moments.[1][2][3]
Mixlab rides the pet tech and telehealth wave, capitalizing on rising pet humanization trends where owners spend more on premium care amid a booming $150B+ U.S. pet industry.[1][2][3] Timing aligns with post-pandemic vet shortages and demand for digital health solutions, enabling remote prescription fulfillment that reduces clinic burdens and improves access.[1][2] Market forces like e-commerce growth in animal health and compounding pharmacy regulations favor its model, influencing the ecosystem by setting standards for tech-vet partnerships and inspiring similar platforms in personalized pet meds.[1][4][5]
Mixlab is poised for continued expansion through acquisitions and tech enhancements, potentially dominating regional veterinary pharmacy networks while integrating AI for even faster customization.[1][2] Trends like advanced vet telehealth, sustainable compounding, and subscription models will shape its path, amplifying influence as pet care digitizes further. This positions Mixlab as a leader in joyful, efficient animal health solutions, building directly on its mission to personalize care at scale.[1][4]
Key people at Mixlab.
